Cargando…
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States
Cannabis is classified as a schedule I controlled substance by the US Drug Enforcement Agency, meaning that it has no medicinal value. Production is legally restricted to a single supplier at the University of Mississippi, and distribution to researchers is tightly controlled. However, a majority of...
Autores principales: | Thomas, Brian F., Pollard, Gerald T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006560/ https://www.ncbi.nlm.nih.gov/pubmed/27630566 http://dx.doi.org/10.3389/fphar.2016.00285 |
Ejemplares similares
-
Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States
por: Mead, Alice
Publicado: (2019) -
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes
por: Baratta, Francesca, et al.
Publicado: (2019) -
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
por: Russo, Ethan B.
Publicado: (2016) -
Phytocannabinoids Profile in Medicinal Cannabis Oils: The Impact of Plant Varieties and Preparation Methods
por: Dei Cas, Michele, et al.
Publicado: (2020) -
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
por: Montoya, Zackary, et al.
Publicado: (2020)